Hämoptysen und akutes Nierenversagen bei COVID-19

A. Junginger1, M. Brucke2, B. Reiser1, O. Stahn2, G. Braun3
1Abteilung für Innere Medizin und Kardiologie, ADK Klinik Ehingen, Ehingen, Deutschland
2Abteilung für Anästhesie und Intensivmedizin, ADK Klinik Ehingen, Ehingen, Deutschland
3Klinik für Gastroenterologie, Infektiologie, Rheumatologie und Intensivmedizin, Universitätsklinikum Augsburg, Augsburg, Deutschland

Tóm tắt

Der Fall beschreibt die Diagnostik und Therapie eines pulmorenalen Syndroms anhand des Beispiels eines 40-jährigen Patienten, der sich aufgrund einer zunehmenden respiratorischen Insuffizienz und Hämoptysen bei gesicherter COVID-19-Erkrankung in unserer Klinik vorstellte.

Tài liệu tham khảo

Enghard P, Erley C, Schreiber A (2019) Akutes pulmorenales Syndrom auf der Intensivstation. Nephrologe 14:438–445 Geetha D, Jefferson JA (2020) ANCA-associated vasculitis: core curriculum 2020. Am J Kidney Dis 75:124–137 Schirmer JH, Aries PM, de Groot K et al (2017) S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden. Z Rheumatol 76:77–104 Weiss P, Murdoch DR (2020) Clinical course and mortality risk of severe COVID-19. Lancet 395:1014–1015 Bhimraj A, Morgan RL, Shumaker AH et al (2020) Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa478 RECOVERY Collaborative Group, Horby P, Lim WS et al (2020) Dexamethasone in hospitalized patients with Covid-19—Preliminary report. N Engl J Med. https://doi.org/10.1056/NEJMoa2021436 WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S et al (2020) Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. https://doi.org/10.1001/jama.2020.17023 Vishnevetsky A, Levy M (2020) Rethinking high-risk groups in COVID-19. Mult Scler Relat Disord 42:102139 D’Antiga L (2020) Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transpl 26:832–834 Monti S, Balduzzi S, Delvino P et al (2020) Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis 79:667–668 Moeinzadeh F, Dezfouli M, Naimi A et al (2020) Newly diagnosed glomerulonephritis during COVID-19 infection undergoing Immunosuppression therapy, a case report. Iran J Kidney Dis 14:239–242 Monti S, Montecucco C (2020) Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: ‘Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia’ by Guilpain et al. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217555